04 . 02 .2021
Press release
Galderma receives FDA approval for Restylane® Defyne for chin augmentation
18 . 11 .2020
Press release
Galderma launches Dysport® in China for treatment of glabellar lines
17 . 11 .2020
Press release
Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study with Azzalure® / Dysport® (abobotulinumtoxinA)
09 . 10 .2020
Press release
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
10 . 06 .2020
Press release
Galderma global research reveals struggles of people with rosacea and psoriasis of the face experiencing a lack of control and impact on mental wellbeing
12 . 05 .2020
Press release
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
06 . 05 .2020
Press release
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
01 . 05 .2020
Press release
CETAPHIL by Galderma unites forces to focus on hand health and safety with their "In Good Hands" initiative to fight COVID-19
22 . 04 .2020
Press release
Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China